FDA Drug Application (204275) for BREO ELLIPTA by GLAXO GRP LTD

Back to FDA Applications sponsored by GLAXO GRP LTD

Application Number204275
Product Number001
FormPOWDER;INHALATION
Dosage0.1MG/INH;EQ 0.025MG BASE/INH
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBREO ELLIPTA
Active IngredientFLUTICASONE FUROATE; VILANTEROL TRIFENATATE



Back to FDA Applications sponsored by GLAXO GRP LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.